Energy News / Shareholders Foundation, Inc.

NASDAQ:FATE Investor Alert: Investigation over Potential Wrongdoing at Fate Therapeutics, Inc

Via: ReleaseWire

Updated 11:15 AM CDT, Fri, August 10,2018

An investigation on behalf of investors in Fate Therapeutics, Inc. (NASDAQ: FATE) shares over potential wrongdoing at Fate Therapeutics, Inc. was announced and NASDAQ: FATE stockholders should contact the Shareholders Foundation.

San Diego, CA -- (SBWIRE) -- 08/10/2018 -- An investigation was announced for investors in shares of Fate Therapeutics, Inc. (NASDAQ: FATE) concerning potential breaches of fiduciary duties by certain officers and directors at Fate Therapeutics, Inc.

Investors who purchased shares of Fate Therapeutics, Inc. (NASDAQ: FATE) and currently hold any of those NASDAQ: FATE shares have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm concerns whether certain Fate Therapeutics officers and directors breached their fiduciary duties and caused damage to the company and its shareholders.

San Diego, CA based Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders worldwide. Shares of Fate Therapeutics, Inc. grew from $1.48 per share in May 2016 to as high as $14.03 per share in February 2018.

On August 9, 2018, NASDAQ: FATE shares closed at $11.42 per share.

Those who purchased shares of Fate Therapeutics, Inc. (NASDAQ: FATE), have certain options and should contact the Shareholders Foundation.

Contact:
Shareholders Foundation, Inc.
Michael Daniels
3111 Camino Del Rio North - Suite 423
92108 San Diego
Phone: +1-(858)-779-1554
Fax: +1-(858)-605-5739
mail@shareholdersfoundation.com

For more information on this press release visit:
http://www.sbwire.com/press-releases/nasdaqfate-investor-alert-investigation-over-potential-wrongdoing-at-fate-therapeutics-inc-1026891.htm

Media Relations Contact
Michael Daniels
858-779-1554
Email: Click to Email Michael Daniels
Web: http://www.ShareholdersFoundation.com